Vajira Hospital

Dusit 10300

2 studies enrolling now · 2 studies all time

What they study most

Gastric Cancer, Gastroesophageal Junction Cancer, Non-small Cell Lung Cancer

Studies at this site

• Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer — Recruiting now
• Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer — Recruiting now